Providence First Trust’s Thermo Fisher Scientific TMO Stock Holding History

Providence First Trust’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,078	Closed	-$530K	–	231
2026 Q1	$530K	Sell	1,078 -380	-26%	-$206K	0.19%	119
2025 Q4	$845K	Buy	+1,458	New	+$825K	0.29%	81
2024 Q3	–	Sell	-1,248	Closed	-$690K	–	105
2024 Q2	$690K	Hold	1,248	–	–	0.31%	65
2024 Q1	$725K	Hold	1,248	–	–	0.31%	70
2023 Q4	$662K	Hold	1,248	–	–	0.33%	68
2023 Q3	$632K	Sell	1,248 -244	-16%	-$130K	0.35%	64
2023 Q2	$778K	Sell	1,492 -44	-3%	-$23.7K	0.43%	62
2023 Q1	$885K	Hold	1,536	–	–	0.51%	57
2022 Q4	$846K	Hold	1,536	–	–	0.5%	59
2022 Q3	$779K	Sell	1,536 -181	-11%	-$101K	0.47%	58
2022 Q2	$933K	Hold	1,717	–	–	0.52%	54
2022 Q1	$1.01M	Buy	1,717 +224	+15%	+$129K	0.49%	58
2021 Q4	$996K	Buy	+1,493	New	+$932K	0.45%	58

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Providence First Trust's TMO Position: Q2 2026 in Review

Providence First Trust sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 1,078 shares — an estimated $530K sold.

Providence First Trust first reported a position in TMO in Q4 2021 and held it in 13 quarters. The position peaked at $1.01M in Q1 2022. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Providence First Trust reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Providence First Trust sold 1,078 Thermo Fisher Scientific shares in Q2 2026, an estimated $530K.
Providence First Trust first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 13 quarters.
Providence First Trust's Thermo Fisher Scientific position peaked at $1.01M in Q1 2022.
2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Providence First Trust's 13F filing for Q2 2026, filed 27 Jul 2026.